"We showed people with Alzheimer's disease have more gut inflammation," University of Wisconsin psychologist Barbara Bendlin ...
Opens in a new tab or window Investigational transcranial magnetic stimulation that targeted a brain network involved in ...
The Alzheimer's disease drug Kisunla will face major reimbursement challenges in the U.K. after the cost-effectiveness ...
Alzheimer's disease, the most common form of dementia, impacts around 40 million people globally, with numbers expected to ...
Semaglutide, the weight management drug sold as Ozempic and Wegovy, may reduce the risk of Alzheimer's disease by 40% to 70% ...
Nearly 7 million Americans 65 and older are living with Alzheimer’s disease, which gradually destroys memory and thinking ...
More than 6 million Americans are diagnosed with Alzheimer's disease, and with an aging national population, this number is ...
The Alzheimer's Association says more than 122,000 Missourians 65 years and older are battling Alzheimer's Disease, which has ...
Today, Prof. Howard Feldman presented revised diagnostic criteria for Alzheimer's disease at the Clinical Trials on Alzheimer's Disease (CTAD) Conference in Madrid on behalf of the International ...
Roche put forward new data on two of its upcoming, non-invasive blood tests designed to help rule out a diagnosis of ...
A new study reveals that the active ingredient in drugs like Ozempic and Wegovy could lower the risk of developing ...
The National Institutes of Health reports that incidences of Alzheimer's disease and other dementia increased by roughly 148 ...